Richard Childs

2.4k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Richard Childs is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Richard Childs has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Hematology and 5 papers in Oncology. Recurrent topics in Richard Childs's work include Hematopoietic Stem Cell Transplantation (7 papers), Immune Cell Function and Interaction (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Richard Childs is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Immune Cell Function and Interaction (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Richard Childs collaborates with scholars based in United States, Malaysia and India. Richard Childs's co-authors include Susan F. Leitman, Elizabeth J. Read, A. John Barrett, John F. Tisdale, Emmanuel Clave, Nathalie Contentin, David S. Schrump, Cynthia E. Dunbar, W. Marston Linehan and Diane E. Epperson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Richard Childs

17 papers receiving 1.3k citations

Hit Papers

Regression of Metastatic ... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Childs United States 13 644 629 465 245 196 18 1.4k
Junichi Sugita Japan 25 750 1.2× 677 1.1× 465 1.0× 197 0.8× 188 1.0× 117 1.8k
Atsushi Kikuta Japan 21 654 1.0× 337 0.5× 596 1.3× 133 0.5× 212 1.1× 118 1.5k
Matthias Eyrich Germany 27 709 1.1× 752 1.2× 556 1.2× 446 1.8× 233 1.2× 93 1.8k
Margit Mitterbauer Austria 25 1.1k 1.6× 462 0.7× 298 0.6× 221 0.9× 337 1.7× 67 1.7k
Kumi Oshima Japan 23 775 1.2× 372 0.6× 385 0.8× 440 1.8× 182 0.9× 70 1.5k
Yener Koç Türkiye 22 1.1k 1.8× 429 0.7× 566 1.2× 250 1.0× 132 0.7× 84 1.8k
Nathalie Parquet France 21 449 0.7× 281 0.4× 480 1.0× 332 1.4× 205 1.0× 55 1.4k
Dawn Jones United States 17 758 1.2× 744 1.2× 191 0.4× 131 0.5× 148 0.8× 28 1.4k
Edward Kanfer United Kingdom 26 1.1k 1.7× 416 0.7× 477 1.0× 206 0.8× 229 1.2× 55 1.8k
Sandra H. Thomas United States 25 386 0.6× 409 0.7× 978 2.1× 130 0.5× 351 1.8× 60 1.9k

Countries citing papers authored by Richard Childs

Since Specialization
Citations

This map shows the geographic impact of Richard Childs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Childs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Childs more than expected).

Fields of papers citing papers by Richard Childs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Childs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Childs. The network helps show where Richard Childs may publish in the future.

Co-authorship network of co-authors of Richard Childs

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Childs. A scholar is included among the top collaborators of Richard Childs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Childs. Richard Childs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Solis, Jamie, et al.. (2019). 021 Fludarabine-induced subacute, often fatal leukoencephalopathy: a case series. Journal of Neurology Neurosurgery & Psychiatry. 90(12). A16.1–A16. 1 indexed citations
2.
Reoma, Lauren, Christopher Trindade, Maria Chiara Monaco, et al.. (2019). Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy. Annals of Neurology. 86(6). 878–884. 25 indexed citations
3.
Ito, Sawa, Priyanka A. Pophali, Gary A. Fahle, et al.. (2013). CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplantation. 48(10). 1313–1316. 79 indexed citations
4.
Olive, Michelle, Jason A. Mellad, Leilani E. Beltran, et al.. (2008). p21Cip1 modulates arterial wound repair through the stromal cell–derived factor-1/CXCR4 axis in mice. Journal of Clinical Investigation. 118(6). 2050–61. 51 indexed citations
5.
Zonios, Dimitrios, Juan Gea‐Banacloche, Richard Childs, & John E. Bennett. (2008). Hallucinations during Voriconazole Therapy. Clinical Infectious Diseases. 47(1). e7–e10. 99 indexed citations
7.
Horne, McDonald K., Donna Jo McCloskey, Karim A. Calis, et al.. (2006). Use of Heparin versus Lepirudin Flushes to Prevent Withdrawal Occlusion of Central Venous Access Devices. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(9). 1262–1267. 18 indexed citations
8.
Montero, Aldemar, Bipin N. Savani, Roger Kurlander, et al.. (2005). Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. British Journal of Haematology. 130(5). 733–739. 12 indexed citations
9.
Nakamura, Ryotaro, Minoo Battiwalla, Scott R. Solomon, et al.. (2004). Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biology of Blood and Marrow Transplantation. 10(1). 49–57. 49 indexed citations
10.
Read, E.J., Susan F. Leitman, Charles D. Bolan, et al.. (2004). A Comparison of Apheresis Cell Content Collected from the Same Donors Mobilized with Granulocyte Colony Stimulating Factor (G-CSF) Vs. a Single Injection of AMD3100.. Blood. 104(11). 2853–2853. 3 indexed citations
11.
Chakrabarti, Sakti & Richard Childs. (2003). Allogeneic immune replacement as cancer immunotherapy. Expert Opinion on Biological Therapy. 3(7). 1051–1060.
12.
Kang, Elizabeth M., Moniek de Witte, Harry L. Malech, et al.. (2002). Gene Therapy–based Treatment for HIV-Positive Patients with Malignancies. Journal of Hematotherapy & Stem Cell Research. 11(5). 809–816. 15 indexed citations
13.
Khuu, Hanh, Claude Kasten-Sportès, Alan S. Wayne, et al.. (2002). Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy. 4(6). 539–549. 27 indexed citations
14.
Horwitz, Mitchell E., A. John Barrett, Margaret R. Brown, et al.. (2001). Treatment of Chronic Granulomatous Disease with Nonmyeloablative Conditioning and a T-Cell–Depleted Hematopoietic Allograft. New England Journal of Medicine. 344(12). 881–888. 198 indexed citations
15.
Barrett, John & Richard Childs. (2000). Non‐myeloablative stem cell transplants. British Journal of Haematology. 111(1). 6–17. 16 indexed citations
16.
Childs, Richard, Nathalie Contentin, Erkut Bahceci, et al.. (2000). Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation. New England Journal of Medicine. 343(11). 750–758. 770 indexed citations breakdown →
17.
Rhee, Frits van, Martha Kirby, Dimitriοs Mavroudis, et al.. (1999). Human G‐CSF‐mobilized CD34‐positive peripheral blood progenitor cells can stimulate allogeneic T‐cell responses: implications for graft rejection in mismatched transplantation. British Journal of Haematology. 105(4). 1014–1024. 13 indexed citations
18.
Hakim, Fran, et al.. (1996). Development of paroxysmal nocturnal hemoglobinuria after chemotherapy [letter]. Blood. 88(12). 4725–4726. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026